Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy
Related Posts
Deboo A, Fox R, Hammitt KM, Frantsve-Hawley J, Baker MC, Danielides S, De Sousa E, Goodman BP, King JK, Mandel S, Noaiseh G, Pavlakis PP,[...]
Tantisattamo E, Hanna RM, Kalantar-Zadeh K. Implementing novel tools for enhancing diagnostic and therapeutic capacities to promote global public health and outcomes in kidney disease[...]
Sharma R, Dao KT, Garcia-Corella J, Dhillon H, Kalha I, Kim S, Stull WR, Petersen G. Unraveling the Complexity: A Case of Systemic Lupus Erythematosus,[...]